Compare BAER & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAER | NAUT |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.0M | 125.4M |
| IPO Year | 2023 | 2020 |
| Metric | BAER | NAUT |
|---|---|---|
| Price | $1.16 | $0.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $5.00 | $4.00 |
| AVG Volume (30 Days) | ★ 1.1M | 841.1K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.15 | 16.07 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $122,830,000.00 | N/A |
| Revenue This Year | $16.47 | N/A |
| Revenue Next Year | N/A | $992.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 24.56 | N/A |
| 52 Week Low | $1.12 | $0.62 |
| 52 Week High | $3.44 | $4.31 |
| Indicator | BAER | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 27.78 | 28.19 |
| Support Level | $1.12 | $0.84 |
| Resistance Level | $2.03 | $2.30 |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 3.68 | 31.00 |
Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Its revenues is derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation services. The company's portfolio is organized across three offerings namely : Fire Suppression; Aerial Surveillance; and Maintenance, Repair and Overhaul (MRO). The company operates as a single operating segment. Its revenues are derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation service. Geographically, it operates in Spain and United States.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.